Back to results
US 11,951,081 B2Granted
Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
AssigneeLaboratorios Silanes S.A. de C.V.
InventorJorge González-Canudas
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to metformin glycinate and methods of using metformin glycinate for the treatment of diseases including diabetes mellitus, obesity, dyslipidemia, diseases associated with IL-10 up-regulation, and diseases or disorders associated with elevated or increased ceramide levels. Pharmaceutical formulations comprising metformin glycinate are also disclosed.
Claims18
A method of treating diabetes comprising the step of:
- administering to a subject in need thereof a therapeutically effective amount of metformin glycinate in combination with one or more additional antidiabetic agents selected from the group consisting of a sulfonylurea, a thiazolidinedione, a dipeptidyl peptidase 4 (DPP4) inhibitor, a sodium/glucose cotransporter 2 (SGLT2) inhibitor, a glucagon-like peptide-1 (GLP1) receptor agonist, glucagon like peptide-1 (GLP-1), and insulin.
A pharmaceutical composition, comprising:
- (i) metformin glycinate;
- and
- (ii) (a) one or more antidiabetic agents selected from the group consisting of a sulfonylurea, a thiazolidinedione, a DPP4 inhibitor, a SGLT2 inhibitor, a GLP1 receptor agonist, GLP-1, and insulin.
Dependencies are inferred from the claim text.